BJUI provides the highest standard of research and clinical info, promoting awareness of advances and supporting best practice | Editor-in-Chief: Freddie Hamdy
Nice summary of Artificial Intelligence >> Machine Learning >> Deep Learning from @michael_gorin
to kick off @BJUIjournal session at #AUA25
Will image segmentation CNNs provide answer to IDing "potentially lethal" prostate cancer (on MRI or histology)? I think so!
#SPACE_Study
@lawrentschuk lays out a nice template for how to safely employ existing (& future) #AI modalities in urological practice
@BJUIjournal session at #AUA25
S-afe for patients & staff
A-fforable & accurate
F-used with existing technologies
E-asy to use
Great demo of AI-scribes
📢 Excited to share our latest study in @BJUIjournal ChatGPT-4 aligned well with humans on assessing quality of YouTube videos on ED treatments, but struggled with source reliability & identifying uncertainty.
Full text in thread👇🏽
The protocol paper for the IP8-FLUORESCE trial is now published #openaccess in @BJUIjournal! Excellent work led by @NikhilMayor and @SageOfLondon1
Keep tuned for the results!
Read for free: buff.ly/48ZquK5
Incredibly rewarding week in Hawassa 🇪🇹 with the #Urolink team - 11 PCNLs in 4 days with excellent progress by the local team and an inaugural national bootcamp for trainees - exciting times ahead for Ethiopian Urology! @MrWillFinch@shekharbiyani@BAUSendourology@BJUIjournal
Primary RPLND, performed by experienced surgeons, has good peri-operative outcomes. Recurrence is more common than with standard treatment, but long-term survival and functional data are limited, although promising. @lawrentschukdoi.org/10.1111/bju.16536
Comparative effectiveness of iRARC vs. ORC for #BladderCancer: findings from a real life study show better perioperative outcomes with similar cancer control and ureteroileal stricture outcomes after iRARC
@ThoSeisendoi.org/10.1111/bju.16565